These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2933591)

  • 1. Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine.
    Brunello N; Volterra A; Cagiano R; Ianieri GC; Cuomo V; Racagni G
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):20-2. PubMed ID: 2933591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pivotal role for serotonin (5HT) in the regulation of beta adrenoceptors by antidepressants: reversibility of the action parachlorophenylalanine by 5-hydroxytroptophan.
    Manier DH; Gillespie DD; Steranka LR; Sulser F
    Experientia; 1984 Nov; 40(11):1223-6. PubMed ID: 6094233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gangliosides enhance behavioral and neurochemical effects induced by chronic desipramine (DMI) treatment.
    Molina VA; Keller EA; Orsingher OA
    Eur J Pharmacol; 1989 Jan; 160(2):247-52. PubMed ID: 2547628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of beta-adrenoceptor down regulation in the desipramine action in the forced swimming test.
    Kitada Y; Miyauchi T; Kosasa T; Satoh S
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):31-5. PubMed ID: 2874504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and chronic desipramine treatment on somatostatin receptors in brain.
    Gheorvassaki EG; Thermos K; Liapakis G; Spyraki C
    Psychopharmacology (Berl); 1992; 108(3):363-6. PubMed ID: 1355925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of chronic desipramine treatment on rat brain adrenergic alpha 2-receptor].
    Sekiya Y; Sugita R; Naitoh H; Kunimi Y; Nomura S
    Yakubutsu Seishin Kodo; 1991 Aug; 11(4):245-55. PubMed ID: 1665932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
    Breese GR; Cooper BR; Mueller RA
    Br J Pharmacol; 1974 Oct; 52(2):307-314. PubMed ID: 4155993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic desmethylimipramine or electroconvulsive shock on selected brain and platelet neurotransmitter recognition sites.
    Abel MS; Clody DE; Wennogle LP; Meyerson LR
    Biochem Pharmacol; 1985 Mar; 34(5):679-83. PubMed ID: 2983735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
    Dewar KM; Grondin L; Carli M; Lima L; Reader TA
    J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of p-chlorophenylalanine on cerebral serotonin binding, serotonin concentration and motor activity in the rat.
    Steigrad P; Tobler I; Waser PG; Borbély AA
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):143-8. PubMed ID: 153478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep, depression and the effects of antidepressant drugs.
    Gaillard JM; de St Hilaire-Kafi S
    Acta Psychiatr Belg; 1985; 85(5):561-7. PubMed ID: 2936061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Eur J Pharmacol; 1991 Mar; 195(1):63-73. PubMed ID: 2065713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain.
    Shirayama Y; Nishikawa T; Umino A; Takahashi K
    Eur J Pharmacol; 1993 Jun; 237(1):117-26. PubMed ID: 8359206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical and behavioral consequences of mild, uncontrollable shock: effects of PCPA.
    Edwards E; Johnson J; Anderson D; Turano P; Henn FA
    Pharmacol Biochem Behav; 1986 Aug; 25(2):415-21. PubMed ID: 2945212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p-Chlorophenylalanine effects on shock-induced attack and pressing responses in rats.
    Sewell RG; Gallus JA; Gault FP; Cleary JP
    Pharmacol Biochem Behav; 1982 Nov; 17(5):945-50. PubMed ID: 6217467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of non-selective monoamine oxidase inhibitors, tranylcypromine and nialamide, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E; Wozniak KM
    J Psychiatr Res; 1984; 18(2):191-203. PubMed ID: 6235366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the role of 5-hydroxytryptamine in the attenuation of presynaptic alpha 2-adrenoceptor-mediated responses by antidepressant treatments.
    Heal DJ; Hurst EM; Prow MR; Buckett WR
    Psychopharmacology (Berl); 1990; 101(1):100-6. PubMed ID: 2160663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.